Gardner Lewis Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
Sell
-293,525
Closed -$52M 79
2020
Q1
$52M Buy
293,525
+94,625
+48% +$17.8M 8.62% 1
2019
Q4
$38M Buy
198,900
+158,900
+397% +$28.7M 5.18% 6
2019
Q3
$6.73M Buy
+40,000
New +$6.52M 1.01% 25
2016
Q4
Sell
-13,638
Closed -$3.14M 125
2016
Q3
$3.14M Buy
13,638
+3,955
+41% +$966K 0.25% 55
2016
Q2
$2.24M Buy
9,683
+4,017
+71% +$926K 0.24% 68
2016
Q1
$1.52M Buy
+5,666
New +$1.62M 0.3% 56

Other funds holding AGN

Gardner Lewis Asset Management's AGN Position: Q2 2020 in Review

Gardner Lewis Asset Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 293,525 shares — an estimated $52M sold.

Gardner Lewis Asset Management first reported a position in AGN in Q1 2016 and held it in 6 quarters. The position peaked at $52M in Q1 2020. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.

  • Gardner Lewis Asset Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
  • Gardner Lewis Asset Management sold 293,525 Allergan plc shares in Q2 2020, an estimated $52M.
  • Gardner Lewis Asset Management first reported a position in Allergan plc in Q1 2016 and held it in 6 quarters.
  • Gardner Lewis Asset Management's Allergan plc position peaked at $52M in Q1 2020.
  • 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.

Based on Gardner Lewis Asset Management's 13F filing for Q2 2020, filed 14 Aug 2020.